We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

169 hedge funds and large institutions have $655M invested in Ariad Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 44 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 44

4% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 24

0% more funds holding

Funds holding: 169169 (0)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

17% less capital invested

Capital invested by funds: $790M → $655M (-$135M)

23% less call options, than puts

Call options by funds: $20.5M | Put options by funds: $26.5M

Holders
169
Holders Change
Holders Change %
0%
% of All Funds
4.9%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
25
Increased
61
Reduced
44
Closed
24
Calls
$20.5M
Puts
$26.5M
Net Calls
-$6.01M
Net Calls Change
-$11M
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
$1.71M +$407K +69,671 +28%
AllianceBernstein
52
AllianceBernstein
Tennessee
$1.68M
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$1.65M +$21.2K +3,628 +1%
ABI
54
Adamant Biomedical Investments
Switzerland
$1.62M +$1.75M +300,000 New
PI
55
Putnam Investments
Massachusetts
$1.48M +$22K +3,775 +1%
EEG
56
E.E. Geduld
$1.47M +$158K +27,100 +11%
Wells Fargo
57
Wells Fargo
California
$1.31M +$818K +140,114 +138%
TA
58
Teachers Advisors
New York
$1.23M -$28.4K -4,871 -2%
Swiss National Bank
59
Swiss National Bank
Switzerland
$1.06M
VAM
60
Visium Asset Management
New York
$1.02M +$989K +169,298 +870%
State Board of Administration of Florida Retirement System
61
State Board of Administration of Florida Retirement System
Florida
$988K -$649K -111,080 -38%
NCMW
62
Northern Capital Management (Wisconsin)
Wisconsin
$988K +$202K +34,525 +23%
ProShare Advisors
63
ProShare Advisors
Maryland
$874K -$228K -39,098 -19%
SFM
64
Soros Fund Management
New York
$810K -$4.96M -850,000 -85%
JCM
65
JS Capital Management
New York
$810K +$876K +150,000 New
SC
66
Skylands Capital
Wisconsin
$778K -$148K -25,400 -15%
Deutsche Bank
67
Deutsche Bank
Germany
$774K -$5.34M -915,091 -86%
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
$769K +$2.45K +420 +0.3%
American Century Companies
69
American Century Companies
Missouri
$760K +$4.34K +744 +0.5%
ST
70
Spot Trading
Illinois
$723K +$238K +40,720 +44%
MLICM
71
Metropolitan Life Insurance Company (MetLife)
New York
$693K
NFA
72
Nationwide Fund Advisors
Ohio
$688K +$1.69K +289 +0.2%
FSA
73
Franklin Street Advisors
North Carolina
$672K +$64.8K +11,100 +10%
ARTA
74
A.R.T. Advisors
New York
$651K +$705K +120,670 New
PIM
75
Platinum Investment Management
Australia
$606K

ARIA Hedge Fund Activity: Q3 2014 in Review

169 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q3 2014, worth a combined $655M — down 17% from $790M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ARIA positions and 24 closed out — a net gain of 1 holder — while 61 added to existing stakes and 44 trimmed.

The largest buyer was Columbus Circle Investors, opening a new position worth an estimated $13.6M. The largest seller was Franklin Resources, exiting entirely with an estimated $32.1M sold.

  • 169 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $655M of Ariad Pharmaceuticals Inc stock for Q3 2014, down 17% quarter-over-quarter.
  • 25 funds opened new Ariad Pharmaceuticals Inc positions in Q3 2014 and 24 closed out, a net change of +1 holder.
  • The largest Ariad Pharmaceuticals Inc buyer in Q3 2014 was Columbus Circle Investors, an estimated $13.6M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q3 2014 was Franklin Resources, an estimated $32.1M sold.

Based on aggregated 13F filings for Q3 2014.